SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-16-032503
Filing Date
2016-12-06
Accepted
2016-12-06 19:36:56
Documents
1
Period of Report
2016-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 4224
  Complete submission text file 0001179110-16-032503.txt   5790
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Swisher Daniel N JR (Reporting) CIK: 0001323113 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51531 | Film No.: 162037410